State of Wisconsin Investment Board
SPRY icon

State of Wisconsin Investment Board’s ARS Pharmaceuticals SPRY Stock Holding History

State of Wisconsin Investment Board’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$575K Buy
+71,627
New +$686K ﹤0.01% 1926
2025
Q4 		– Sell
-53,402
Closed -$537K – 2547
2025
Q3 		$537K Buy
53,402
+35,845
+204% +$514K ﹤0.01% 1855
2025
Q2 		$306K Sell
17,557
-36,679
-68% -$529K ﹤0.01% 2055
2025
Q1 		$682K Sell
54,236
-46,637
-46% -$561K ﹤0.01% 1626
2024
Q4 		$1.06M Buy
100,873
+73,963
+275% +$1.04M ﹤0.01% 1503
2024
Q3 		$390K Hold
26,910
– – ﹤0.01% 1971
2024
Q2 		$229K Sell
26,910
-14,515
-35% -$129K ﹤0.01% 2116
2024
Q1 		$423K Buy
41,425
+10,619
+34% +$79.2K ﹤0.01% 1837
2023
Q4 		$169K Sell
30,806
-1,444
-4% -$6.33K ﹤0.01% 2225
2023
Q3 		$122K Sell
32,250
-734
-2% -$4.82K ﹤0.01% 2342
2023
Q2 		$221K Buy
+32,984
New +$220K ﹤0.01% 2110
2022
Q4 		– Sell
-24,200
Closed -$128K – 2639
2022
Q3 		$128K Sell
24,200
-48,300
-67% -$238K ﹤0.01% 2493
2022
Q2 		$307K Buy
+72,500
New +$253K ﹤0.01% 2315
2021
Q4 		– Sell
-16,500
Closed -$165K – 2207
2021
Q3 		$165K Buy
16,500
+10,012
+154% +$247K ﹤0.01% 2087
2021
Q2 		$200K Buy
+6,488
New +$208K ﹤0.01% 2036

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State of Wisconsin Investment Board's SPRY Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in ARS Pharmaceuticals (SPRY) in Q1 2026: 71,627 shares worth $575K. The stake represents ﹤0.01% of the portfolio and ranks #1926 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in SPRY as recently as Q3 2025.

State of Wisconsin Investment Board first reported a position in SPRY in Q2 2021 and has held it in 15 quarters since. The position peaked at $1.06M in Q4 2024. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • State of Wisconsin Investment Board held 71,627 shares of ARS Pharmaceuticals worth $575K as of Q1 2026.
  • ARS Pharmaceuticals was a new State of Wisconsin Investment Board position in Q1 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1926 holding.
  • State of Wisconsin Investment Board first reported a position in ARS Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • State of Wisconsin Investment Board's ARS Pharmaceuticals position peaked at $1.06M in Q4 2024.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.